ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : National Institutes of Health : National Cancer Institute (NCI)


Include trials that are no longer recruiting patients.

1462 studies were found. Here are studies 1 to 50.
1.Recruiting12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
2.Recruiting17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer
3.Recruiting17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer
4.Recruiting17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas
Conditions: adult solid tumor; Leukemia; Lymphoma
5.Recruiting17-DMAG to Treat Patients with Solid Tumors or Lymphomas
Conditions: Neoplasms; Lymphoma
6.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor
Condition: unspecified adult solid tumor, protocol specific
7.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
Condition: Cancer
8.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma
9.Not yet recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
10.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ...
11.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Stage III or Stage IV Melanoma
Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
12.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer
Conditions: stage I renal cell cancer; von Hippel-Lindau Syndrome
13.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma
14.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: unspecified childhood solid tumor, protocol specific; recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; ...
15.Recruiting17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease
Conditions: Hippel-Lindau Disease; Kidney Cancer
16.Recruiting2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Conditions: refractory plasma cell neoplasm; stage III multiple myeloma; unspecified adult solid tumor, protocol specific
17.Not yet recruiting3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
18.Recruiting3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
19.Recruiting3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
20.Recruiting3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
Condition: Non-small cell lung cancer
21.Recruiting3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
22.Recruiting3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer
Conditions: unresectable extrahepatic bile duct cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; recurrent extrahepatic bile duct cancer; ...
23.Recruiting3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia
24.Recruiting3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
25.Recruiting3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome
Conditions: acute leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; chronic leukemia; ...
26.Recruiting3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
27.Recruiting3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Conditions: recurrent esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus
28.Recruiting3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection
Conditions: stage I breast cancer; stage II breast cancer
29.Recruiting506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: recurrent adult acute lymphoblastic leukemia; T-cell adult acute lymphoblastic leukemia; recurrent adult lymphoblastic lymphoma
30.RecruitingABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
31.RecruitingABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma
Conditions: Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
32.RecruitingABI-007, Carboplatin, and Trastuzumab in Treating Patients With HER2/neu-Overexpressing Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer
33.RecruitingABT-751 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That is Refractory to Taxane Therapy
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
34.RecruitingABT-751 in Treating Young Patients With Refractory Solid Tumors
Condition: childhood cancer
35.RecruitingABX-EGF in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Chemotherapy
Conditions: adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; ...
36.RecruitingThe Acquisition of Blood and Skin Samples from Normal Volunteers to Support Research Activities on Dermatologic Diseases
Conditions: Healthy; Skin Disease
37.RecruitingAcupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
Conditions: Breast Cancer; nausea and vomiting
38.RecruitingAcupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Conditions: Cancer; oral complications of cancer and cancer therapy; Pain
39.RecruitingAdjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
Conditions: stage II multiple myeloma; stage III multiple myeloma
40.RecruitingAdjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
41.RecruitingAdjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
Conditions: stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
42.Not yet recruitingAdjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
43.RecruitingAdjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer; Male Breast Cancer
44.RecruitingAdjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Conditions: Colon Cancer; liver metastases; Rectal Cancer
45.RecruitingAdjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; breast cancer in situ
46.RecruitingAdjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
47.RecruitingAdjuvant Oxaliplatin and Capecitabine Compared With Fluorouracil and Leucovorin in Treating Chemotherapy-Naïve (Not Previously Treated) Patients Who Have Undergone Resection for Stage III Colon Cancer
Condition: stage III colon cancer
48.RecruitingAdjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma
Conditions: Recurrent Melanoma; stage I melanoma; stage II melanoma; stage III melanoma
49.RecruitingAdjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Conditions: stage III prostate cancer; stage II prostate cancer
50.Not yet recruitingAdoptive Immunotherapy and Interleukin-2 in Treating Patients With Recurrent Accelerated or Blast Phase Chronic Myelogenous Leukemia After Undergoing Allogeneic Stem Cell Transplantation
Conditions: accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act